Navigation Links
New treatment effective for patients with shoulder pain
Date:9/24/2007

Inflammation of a tendon triggered by calcium deposits, or calcific tendinitis, can effectively be treated with a simple and cost effective percutaneous method according to a recent study conducted by researchers from the Hospital de Basurto in Bilbao, Spain.

We started treating calcific tendinitis as the result of the request of several members of our hospital staff that were suffering with this condition, said Jose Luis del Cura, MD, lead author of the study. The results we obtained in these few cases encouraged us to offer this treatment to our patients. Later, in collaboration with the rheumatology department of our hospital, we conducted a study to evaluate the efficacy of the procedure, said Dr. del Cura.

The study consisted of 67 shoulders that were treated with sonographically guided percutaneous needle lavage i.e. injections of lydocaine or saline. According to the study, one year after treatment, 91% of shoulders had considerably or completely improved. Of the 67 shoulders treated, 64% had perfect motion and the calcifications had resolved completely or nearly completely in 89% of the patients.

A significant amount of the patients (about half of them) experienced a transitory limited recurrence about two months after the treatment, which we found surprising, said Dr. del Cura. When the recurrence did occur, the symptoms were different; milder and predominately at night, lasted several weeks and finally disappeared, usually without sequels. We hypothesized that this may have been the result of reparative changes inside the tendon, he said.

The results showed us that aspiration and lavage is a very efficacious technique in the treatment of calcific tendinitis. Calcific tendinitis is common and is highly disabling, said Dr. del Cura. It has a significant social impact since it usually involves middle-aged labor-active people and costs thousands of dollars in working hours lost. The alternatives to percutaneous t
'/>"/>

Contact: Necoya Lightsey
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. Now umbilical cord helps in stroke treatment.
6. Now AIDS treatment comes dirt-cheap
7. Breast cancer treatment to be determined by gene test
8. Hemopurifier may revolutionise AIDS treatment
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Biocides are chemical substances, which are ... fungi growth and to prevent degradation of the physical ... its surface. It is used in various applications such ... beverage, paints and coatings. It is also used in ... as in industrial applications to prevent fouling in water ...
(Date:7/29/2014)... JOLLA, Calif. (PRWEB) July 29, 2014 ... a comprehensive overview of the hepatitis C (hep C) ... the potential of these treatments to reduce human suffering. ... understanding of the impact of hep C, while highlighting ... a new era of treatment. CHI is a nonprofit, ...
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Decorative contact lenses may ... careful, they can cause serious eye damage. Decorative ... ophthalmologist, according to the U.S. Food and Drug Administration ... a valid prescription for these lenses and buy them ... spread the word about the potential health risks associated ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Transformer Oil ... market in Europe with analysis and forecast of revenue. The ... around $0.3 billion in 2013 to $0.5 billion by 2018, ... Browse through the TOC of the Transformer Oil Market in ... provided. This also provides a glimpse of the segmentation in ...
(Date:7/29/2014)... 29, 2014Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) ... partnership to improve access to essential pain medications for ... of ACS, Treat the Pain initiative, this new partnership ... into HIV/AIDS services throughout the country. , Swaziland ... more than 26 percent of adults ages 15-49 infected. ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 4Health News:It's 'Buyer Beware' for Decorative Contact Lenses, FDA Says 2Health News:Europe Transformer Oil Market is Expected to Reach $0.5 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Transformer Oil Market is Expected to Reach $0.5 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Transformer Oil Market is Expected to Reach $0.5 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:New partnership to improve access to essential pain medications for people living with HIV 2
... 26 You know that the HPV (human,papillomavirus) ... Is there a,theoretical basis for exploring its use ... a 3-part CME Webcast, assesses this,and other issues ... online,offering from Sexuality, Reproduction and Menopause (SRM), a ...
... combative kids , , TUESDAY, Feb. 26 (HealthDay News) -- For ... biological reason for all the family feuding -- adolescent brain ... when key regions of the brain known for controlling emotions ... and more persistent during their fights with Mom and Dad. ...
... 26 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... M.D. vice president of clinical research. In this ... the direction and,oversight of Rigel,s clinical research programs ... R788, oral syk kinase,inhibitor, is expected to enter ...
... Quality Cardiology Center Seeks End to Soaring Health Costs, ... Hospital,one of the nation,s leading cardiology treatment centers, announced ... for one of the most common types of,open heart ... Wichita,Eagle published this week. "After carefully studying our costs ...
... 26 EntreMed, Inc.,(Nasdaq: ENMD ) a ... cancer and inflammatory diseases, today,announced that James S. ... Corporate overview at the Jesup & Lamont Emerging ... Disney Contemporary Resort in,Orlando, Florida on Thursday, February ...
... Lt. Gov. David A. Paterson, along with stem cell experts Arnold ... will be the keynote speakers at the 3rd Annual Stem Cell ... Hilton New York ... 1335 Avenue of the Americas, WHAT: Largest gathering of stem ...
Cached Medicine News:Health News:Experts Delve Into Issues of HPV Vaccination 2Health News:Teen Aggression May Really Be a State of Mind 2Health News:Teen Aggression May Really Be a State of Mind 3Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 3Health News:EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference 2Health News:MEDIA ADVISORY: New York Lt. Gov. David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit 2
(Date:7/29/2014)... 29, 2014 According to a ... Trauma Fixation Devices Market - Global Forecast, Market Share, ... global orthopedic trauma fixation devices market is estimated at ... grow at a CAGR of 7.2% from 2014 to ... billion in 2020. Browse the Orthopedic Trauma ...
(Date:7/29/2014)... CITY and TORONTO ... EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging ... the development of improved novel formulations and ... molecules announces expansion of its pharmaceutical development ... development direction includes large molecule drugs that will ...
(Date:7/29/2014)... VIEW, Calif. , July 29, 2014 /PRNewswire/ ... emergency response systems (PERS) market, Frost & Sullivan ... & Sullivan Award for Price Performance Value Leadership. ... usage directly captures expectations for tech progression in ... US consumers for these solutions. MobileHelp ...
Breaking Medicine Technology:Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 2Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 3
... 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... LLY ) and Alkermes, Inc. (Nasdaq: ... the DURATION-3 and -4 trials demonstrating patients treated ... injectable suspension) experienced significant improvements in select cardiovascular ...
... and UTRECHT, The Netherlands, September 12, 2011 ... ("Silence"), a leading global RNA interference ( RNAi ) ... company developing pathway targeted microRNA ("miRNA")-based therapeutics for cancer, ... to develop novel microRNA therapeutics for the treatment of ...
Cached Medicine Technology:Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 2Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 3Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 4Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 5Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 6Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 7Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 8Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 9Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics 2Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics 3Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics 4Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics 5Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics 6
... Davis's Drug Guide 10th ... Updates include 200 new drug ... indexes and a new Bookmark ... answers you need. Includes PDA, ...
Davis's Drug Guide for Nurses - now with over 760 Integrated Calculators - combines the most comprehensive, up-to-date and practical drug resource with built in drug dosing calculation tools for most...
... The Concise Guide to Drug Interaction Principles ... written expressly for clinicians. , An understanding ... the practice of medicine. Since publication of ... in 2001, our increasing pharmacopoeia - coupled ...
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician....
Medicine Products: